Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2‘,3‘-dideoxynucleoside analogs in resting and activated human cells.

This publication has 25 references indexed in Scilit:

• A Pilot Study of Sequential Therapy with Zidovudine plus Acyclovir, Dideoxyinosine, and Dideoxycytidine in Patients with Severe Human Immunodeficiency Virus Infection
  The Journal of Infectious Diseases, 1993
• Present Status and Future Prospects for HIV Therapies
  Science, 1993
• Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
  Journal of Clinical Investigation, 1993
• Detection of Human Immunodeficiency Virus Type 1 Provirus in Mononuclear Cells by in Situ Polymerase Chain Reaction
  New England Journal of Medicine, 1992
• Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs
  Biochemical and Biophysical Research Communications, 1991
• Molecular Targets for AIDS Therapy
  Science, 1990
• HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
  Cell, 1990
• Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV
  Journal of Medicinal Chemistry, 1990
• Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
  The Journal of Experimental Medicine, 1989
• Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA
  Cell, 1977